MD-2/LY96 active protein

Human MD-2/LY96

Cat. Num. AAA692523

• Gene Names: LY96; MD2; MD-2; ly-96; ESOP-1
• Purity: >= 90% by SDS-PAGE gel and HPLC analyses.
• Synonyms: MD-2/LY96; Human MD-2/LY96; Myeloid differentiation protein-2; Lymphocyte antigen 96; ESPO-1; LY96; MD2; MD-2; ly-96; MD-2/LY96 active protein

• Host: HEK 293 Cells
• Purity/Purification: >= 90% by SDS-PAGE gel and HPLC analyses.
• Form/Format: Lyophilized
• Sequence: QKQYWVCNSS DASISYTYCD KMQYPISINV NPCIELKGSK GLLHIF YIPR RDLKQLYFNL YITVNTMNLP KRKEVICRGS DDDYSFCRAL K GETVNTTIS FSFKGIKFSK GKYKCVVEAI SGSPEEMLFC LEFVILH QPN SNHHHHHH
• Sequence Length: 130

• Species: Human
• Biological Activity: Determined by its ability to bind rhMD-2 in a functional ELISA.
• Tag: His-Tag
• Reconstitution: Centrifuge the vial prior to opening!

Related Product Information for MD-2/LY96 active protein

Myeloid differentiation protein-2 (MD-2), also referred to as LY69, is an accessory glycoprotein secreted in hematopoietic, nervous, and reproductive tissues at various stages of development where it regulates innate immune responses to microbial pathogens through interaction with the extracellular do mains of TLR-2 and TLR-4. The association of MD-2 with the extracellular domain of TLR-4, which is constitutively expressed in cells of the immune system, localizes TLR-4 to the cell surface and forms the TLR-4/MD-2 receptor complex necessary for signal transduction in response to inflammatory signals. The activation of TLR-4/MD-2 begins with the detection of LPS by circulating LPS-Binding Protein (LBP), which in turn facilitates an association between LPS and CD14 for the formation of a CD14/LPS complex that transports and presents LPS to the TLR-4/MD-2 signaling complex, and culminates in the activation of downstream signaling events. MD-2's possession of two dedicated functional domains allows for its simultaneous interaction with both TLR-4 and LPS,the major cell wall component of gram-negative bacteria that acts as the key ligand for TLR-4. Response to LPS is an intricate process that involves several co-stimulatory molecules, including myeloid differentiation factor 88 (MyD88), NF-kappaB, LBP, and CD14, in addition to TLR-4 and MD-2, and results in the secretion of proinflammatory cytokines and chemokines from the NF-kappaB, Wnt/beta-catenin, and mitogen-activated protein kinase (MAPK) pathways. MD-2 interacts with TLR-2 in a similar, albeit far weaker, manner to initiate immune response to cell wall components of both gram-negative and gram-positive bacteria. Once secreted, MD-2 can polymerize into a heterogenous collection of large, disulfide-linked oligomers that are each able to bind several TLR-4 molecules, resulting in large clusters localized to the cell surface prior to activation. The HEK293 cell-derived Recombinant Human MD-2/LY96 is a disulfide-linked homodimer whose monomer contains 148 amino acid residues, including a C-terminal His tag, and has a calculated molecular weight of 17.2 kDa.

NCBI and Uniprot Product Information

• NCBI GI #: 307775409
• NCBI GeneID: 23643
• NCBI Accession #: NP_001182726.1
• NCBI GenBank Nucleotide #: NM_001195797.1
• UniProt Accession #: Q9Y6Y9; B3Y6A5; E5RJJ7
• Molecular Weight: 14,933 Da
• NCBI Official Full Name: lymphocyte antigen 96 isoform 2
• NCBI Official Synonym Full Names: lymphocyte antigen 96
• NCBI Official Symbol: LY96
• NCBI Official Synonym Symbols: MD2; MD-2; ly-96; ESOP-1
• NCBI Protein Information: lymphocyte antigen 96
• UniProt Protein Name: Lymphocyte antigen 96
• UniProt Gene Name: LY96
• UniProt Synonym Gene Names: ESOP1; MD2; Ly-96

NCBI Description

This gene encodes a protein which associates with toll-like receptor 4 on the cell surface and confers responsiveness to lipopolysaccyaride (LPS), thus providing a link between the receptor and LPS signaling. Studies of the mouse ortholog suggest that this gene may be involved in endotoxin neutralization. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2010]

Uniprot Description

Binds bacterial lipopolysaccharide (LPS) (PubMed:17803912, PubMed:17569869). Cooperates with TLR4 in the innate immune response to bacterial lipopolysaccharide (LPS), and with TLR2 in the response to cell wall components from Gram-positive and Gram-negative bacteria (PubMed:11160242, PubMed:11593030). Enhances TLR4-dependent activation of NF-kappa-B (PubMed:10359581). Cells expressing both LY96 and TLR4, but not TLR4 alone, respond to LPS (PubMed:10359581).